autosomal dominant

Cataracts, Anterior Polar with Guttata

Clinical Characteristics
Ocular Features: 

The combination of corneal guttata and anterior polar cataracts has been reported in at least 4 multigenerational families.  Cataracts have their onset in the first decade of life, sometimes as early as 6 months but often are not noted until 3 to 4 years of age.  The polar opacities range in size from that of a small dot to 3 mm in diameter.  These progress slowly and become nearly stationary in early adulthood but can progress sufficiently to interfere with acuity and sometimes require removal by the 3rd or 4th decades of life.  The guttata also appear sometime after birth and are more pronounced centrally.  Histologically the stroma is normal but the epithelium shows some edematous changes and the Descemet membrane progressively thickens with age along with the corneal clouding.  Visual impairment early is generally caused by the lens opacity while later in life corneal edema is more likely the cause.

Vision across a variety of ages ranges from 20/20 to 20/40 in patients with more stationary disease.

Systemic Features: 

No associated systemic disease has been reported.

Genetics

This is a presumed autosomal dominant disorder resulting from heterozygous mutations in the TMCO3 gene (13q34).

Another type of autosomal dominant anterior polar cataract, CTAA2 (601202), but without corneal disease has been mapped to 17p13 and yet another (CTAA1) (115650) is associated with chromosomal aberrations.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Cataract extraction and corneal transplantation can improve vision but are seldom necessary.

References
Article Title: 

Corneal Dystrophy, Congenital Endothelial 1

Clinical Characteristics
Ocular Features: 

(OMIM has combined this disorder with PPCD1 (122000) based on genetic and clinical evidence.)

Early onset limbus-to-limbus corneal clouding is the outstanding feature.  Some asymmetry is often present.  Vision is minimally impaired if at all in many children but slow progression occurs and adults often become visually impaired.  Nystagmus does not develop.  Photophobia and tearing are common.  The corneal appearance can lead to the erroneous diagnosis of congenital glaucoma.  However, some infants actually do have congenital glaucoma as well leading some to suggest this may be a disorder of anterior chamber dysgenesis.  The edematous cornea may be of 2-3 times normal thickness.  It may appear generally hazy and sometimes has a diffuse ground glass appearance.  

The posterior surface often appears mottled and has been described as having a peau d'orange appearance.  The endothelium is attenuated or even absent histologically and abnormal, disorganized collagen fibrils have been found in a thickened Descemet layer by electron microscopy.  The remaining endothelial cells are often vacuolated and heaped in double layers, with some containing melanin granules.  Some atrophy and edema of the epithelium with partial loss of Bowman's can be seen histologically.

Systemic Features: 

No systemic abnormalities are found in this disorder.

Genetics

This is an autosomal dominant disorder that maps to a locus on chromosome 20 (20p11.2-q11.2).   The molecular defect seems to involve the promotor of OVOL2 (20p11.23).  It is of interest that the posterior polymorphous corneal dystrophy 1 (PPCD1, 122000) mutation has been mapped to the same pericentric region, and it has been suggested that the two conditions may be allelic. These are now combined into a single entity in OMIM. 

This disorder should not be confused with congenital endothelial dystrophy type 2, CHED2 (217700) which is autosomal recessive, has an earlier presentation, and maps to a different region of chromosome 20.  Harboyan syndrome (217400) has similar corneal features but maps to a different location on chromosome 20 and is associated with sensorineural deafness.

The nosology of the corneal dystrophies is still evolving.  In the 2015 edition of the IC3D, this condition designated CHED1 is eliminated based on clinical and pathologic similarities to those in posterior polymorphous corneal dystrophy 1 (PPCD1, 122000).  However, while the loci for PPCD2 and CHED1 are located in the same pericentric region of chromosome 20, the purported mutations occur in different genes. 

 

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty carries a good visual prognosis, even when done late in life.

References
Article Title: 

IC3D classification of corneal dystrophies--edition 2

Weiss JS, Moller HU, Aldave AJ, Seitz B, Bredrup C, Kivela T, Munier FL, Rapuano CJ, Nischal KK, Kim EK, Sutphin J, Busin M, Labbe A, Kenyon KR, Kinoshita S, Lisch W. IC3D classification of corneal dystrophies--edition 2. Cornea. 2015 Feb;34(2):117-59. Erratum in: Cornea. 2015 Oct;34(10):e32.

PubMed ID: 
25564336

Corneal Dystrophy, Lattice Type II

Clinical Characteristics
Ocular Features: 

This is a systemic amyloidosis disorder with significant corneal disease.  The corneal stroma contains linear deposits which are more discrete, more peripheral, more delicate, and more radial than those in lattice type I with which it is sometimes confused.  There is also less accumulation of amorphous amyloid material than in type I.  The onset is often later as well, and rarely seen in childhood.  Corneal sensitivity is reduced.  Vision is less affected than in type I lattice dystrophy and patients rarely require keratoplasty, and, if so, later in life.

Amyloid deposits are found in the cornea, sclera, choroid, lacrimal gland, ciliary nerves, and adnexal blood vessels.  Ptosis and extraocular muscle dysfunction is not significant.

Systemic Features: 

Amyloid deposits are found throughout the body including blood vessels, heart, kidney, skin and nerves.  A "mask-like" facies with a protruding lower lip, dry itchy skin, peripheral and cranial neuropathy, and renal failure are clinical features but often have their onset late in life.  Facial paralysis and bulbar palsy may be the result.

Genetics

While this is considered an autosomal dominant disorder, presumed homozygous cases have been reported in Finland where the first cases were described.  These cases seem to have more severe disease with an earlier onset than found among patients with heterozygous mutations.  Mutations in the GSN gene located at 9q34 are responsible.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be beneficial but is rarely needed for visual rehabilitation.  The amyloid deposits may recur in the donor tissue.  The reduced corneal sensitivity secondary to neural involvement increases the risk of post-operative neurotrophic epithelial defects.

References
Article Title: 

Hereditary gelsolin amyloidosis

Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. Handb Clin Neurol. 2013;115:659-81. PubMed PMID: 23931809.

PubMed ID: 
23931809

Corneal Dystrophy, Lattice Type I

Clinical Characteristics
Ocular Features: 

Lattice corneal dystrophy type I is one of the more common corneal dystrophies and occurs throughout the world.  Randomly oriented linear opacities resembling cotton threads accumulate in the central portions of the stroma.  These usually become apparent in the first decade of life although they are sometimes seen in infancy.  The peripheral cornea is relatively spared and intervening stromal areas are clear.  This is a progressive disorder in which vision during childhood is often normal but by the fifth and sixth decades most patients have severe visual impairment due to increasing accumulations of amyloid.  Corneal erosions may occur in the absence of stromal infiltrates.

Systemic Features: 

No systemic disease is found in LCD1 (as opposed to LCD type II).

Genetics

Type I lattice dystrophy is an autosomal dominant disorder as the result of mutations in the TGFBI gene (5q31).  Other corneal dystrophies (granular I or Groenouw type I, combined granular/lattice or Avellino type, Thiel-Behnke, Reis-Bucklers, epithelial basement membrane disease) have mutations in the same region of the same gene casting doubt on the value of using solely clinical and histologic distinctions in current classifications of these corneal disorders.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Recurrent corneal erosions benefit from standard treatments while penetrating keratoplasty may be necessary by the fifth decade to improve acuity.

References
Article Title: 

Corneal Dystrophy, Posterior Amorphous

Clinical Characteristics
Ocular Features: 

The iris abnormalities consisting of iridocorneal adhesions to Schwalbe's line and pupillary abnormalities suggest that PACD is a congenital disorder, perhaps a form of anterior chamber dysgenesis.  The corneal stroma and Descemet membrane contain sheet-like opacities with clear intervening areas.  These opacities are concentrated in the posterior stroma and are sometimes seen from limbus to limbus whereas in other cases they occur mostly peripherally.  The cornea may be thinner than normal and somewhat flattened.  There is little or no progression of the corneal opacification and vision varies widely.  Glaucoma has not been reported.

Histological and EM studies have revealed some fracturing and disorganization of the posterior stromal lamellae and focal attenuation of the endothelium.

Systemic Features: 

There is no associated systemic disease.

Genetics

A limited number of families with this disorder have been reported and the pattern in each is  generally consistent with autosomal dominant inheritance.  This may be a deletion syndrome based on the finding in a 1 year old African male with a heterozygous de novo deletion at 12q21.33-q22 containing 11 genes.  Anong the missing genes are those for the 4 small leucine-rich proteoglycans associated with this form of corneal dystrophy.  The parents did not have the deletion though.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Treatment is generally not required but penetrating keratoplasty can benefit those whose vision is significantly impaired.

References
Article Title: 

EDICT Syndrome

Clinical Characteristics
Ocular Features: 

This is a rare disorder with multiple anterior segment anomalies.  The corneal stroma is thinned in the range of 330 to 460 um with uniform steepening (no cone).  The epithelium may be irregular and edematous, the stroma is diffusely hazy, and the endothelium is irregular with many guttae.  Anterior polar cataracts are likely congenital and often require removal before the age of 20 years.  The pupils are often eccentric and difficult to dilate.  The iris stroma may appear atrophic.  Visual acuity, even in the aphakic condition, is in the range of 20/30 to 20/160.

Histological studies show attenuation of the endothelium with cellular overlapping and aggregates of fibrillar material that stains for cytokeratin.  Descemet membrane is thickened as is the epithelial basement membrane and both intracellular and extracellular lipid deposition is seen throughout the stroma and the Bowman membrane.

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is an autosomal dominant disorder resulting from a heterozygous single base substitution (57C-T) in the MIR184 gene (15q25.1).

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Cataract removal and penetrating keratoplasty can be helpful.  It is unknown whether the donor corneal tissue develops similar opacities.

References
Article Title: 

Corneal Dystrophy, Congenital Stromal

Clinical Characteristics
Ocular Features: 

This rare congenital form of stromal dystrophy is sometimes considered a disorder of collagen fibrils with abnormally small diameters.  These may appear disorganized in areas.  Corneal opacities are often evident at birth or during the neonatal period.  Numerous small spots of fluffy, flaky deposits are found throughout the stroma creating a diffuse cloudy appearance and these may become more numerous with age indicating some progression.  The epithelium, Descemet membrane and the endothelium are not affected and the stroma is of normal or slightly increased thickness.  In some areas abnormal fibrillar layers are seen.  Although corneal erosions and photophobia are usually not clinically significant, acuity may be as low as hand motions and penetrating keratoplasty may be indicated.  In one series this was necessary at an average age of 20 years.  In the same series of 11 patients, 4 had strabismus, 3 eyes developed open angle glaucoma and band keratopathy was present in one patient.  Nystagmus has not been reported.

Deposition of abnormal decorin contributes to the stromal opacities. 

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is a rare autosomal dominant stromal dystrophy that results from a mutation in the DCN gene on chromosome 12 (12q21.3).  Several frameshift mutations have been reported    in the decorin (DCN) gene causing premature truncation of the protein product.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be successful in restoring vision.  Grafts have been reported to remain clear for up to 36 years in more than half of the patients in one series but opacities recurred in others.

References
Article Title: 

Corneal Dystrophy, Schnyder

Clinical Characteristics
Ocular Features: 

Schnyder corneal dystrophy has its onset early in life as a haziness of the central cornea with some peripheral extension.  The stroma gradually becomes more hazy and eventually in about 50% of patients yellow-white crystalline deposits can be seen in an annular pattern in the Bowman layer and the adjacent stroma just beneath. The remaining layers of the cornea are not involved.  The needle-shaped crystals are often birefringent and composed of cholesterol and phospholipids. There is considerable variation in the progression of disease and in the symmetry of disease in the two eyes.  Visual acuity may be relatively good in young people but older patients with denser central opacification eventually require corneal transplantation for better vision.

Systemic Features: 

Some patients have hypercholesterolemia and hyperlipidemia.  Skin fibroblast cultures in one patient have shown cytoplasmic deposits consistent with unesterified cholesterol but another study failed to find such deposits in skin or conjunctiva.  Evidence points to a metabolic disorder of lipid metabolism in the cornea but the evidence for a more generalized systemic disorder is inconclusive.  Genu valgum has been reported in some patients.

Genetics

Schnyder crystalline dystrophy of the cornea results from a mutation in the UBIAD1 gene located on chromosome 1 (1p36.3).  Multiple mutations have been identified.  It is inherited in an autosomal dominant pattern.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be helpful in restoring vision but the corneal deposits and opacification often recur.  PTK procedures can also be beneficial.

References
Article Title: 

Schnyder corneal dystrophy

Weiss JS. Schnyder corneal dystrophy. Curr Opin Ophthalmol. 2009 Jul;20(4):292-8. Review.

PubMed ID: 
19398911

Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function

Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, Karkera J, Mahurkar S, Lisch W, Dupps WJ Jr, White PS, Winters RS, Kim C, Rapuano CJ, Sutphin J, Reidy J, Hu FR, Lu da W, Ebenezer N, Nickerson ML. Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function. Am J Med Genet A. 2008 Feb 1;146(3):271-83. (Note: Erratum: Am. J. Med. Genet. 146A: 952-964, 2008.)

PubMed ID: 
18176953

Corneal Dystrophy, Fleck

Clinical Characteristics
Ocular Features: 

This stromal dystrophy may be congenital as it can be seen in the first years of life.  It is nonprogressive and generally has little clinical significance as it does not impair vision or require treatment in most cases.  It is usually diagnosed on routine examination from the presence of multiple, minute, whitish or grayish discrete opacities throughout the stroma.  The largest numbers are located centrally and posteriorly.  These may be flat, round or oval, and sometimes resemble snowflakes.  Keratocyte cell bodies contain cytoplasmic inclusions or vacuoles likely as the result of defective intracellular organelle trafficking.  Other layers such as the epithelium, Bowman layer, Descemet and endothelium are normal.  Expressivity is highly variable with considerable asymmetry of opacities in the two eyes and even unilateral involvement.

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is an autosomal dominant stromal dystrophy resulting from mutations in the PIKFYVE (PIP5K3) gene on chromosome 2 (2q35).  A variety of missense, frameshift, and protein-truncating mutations have been found.  The gene product is a member of the phosphoinositide 3-kinase family that regulates the synthesis, sorting, and transportation of intracellular multivesicular bodies.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

No treatment is required in most cases.

References
Article Title: 

Corneal Dystrophy, Granular

Clinical Characteristics
Ocular Features: 

The corneal opacities in this disorder are usually located in the anterior stroma of the central cornea, and consist of discrete grayish-white, irregular granules with sharp margins.  The peripheral cornea and areas between the opacities remain clear.  The opacities may be apparent in the first decade but vision remains good throughout childhood.  The epithelial surface is usually smooth in children but adults can develop irregularities.  As the opacities enlarge and grow in number the cornea becomes increasingly opaque and older patients experience considerable loss of vision.  There is some variation in the number of opacities among individuals and considerable clinical heterogeneity occurs both within and between families.  The histologic appearance of the corneal deposits are said to be characteristic with eosinophilic deposits in the anterior stroma secondary to accumulations of mutant transforming growth factor beta induced protein.

The number and morphology of the granular deposits change throughout life, influenced to some extent by episodes of recurrent corneal erosions and age of patients.  Deposits become more annular and lattice-like in morphology, especially in the third decade and become more discoid by the fifth decade. 

It has been reported that the morphology and function of the meibomian glands are altered in this disease as well.

Systemic Features: 

No associated systemic disease has been described.

Genetics

This is another autosomal dominant corneal dystrophy resulting from mutations in the TGFBI gene (5q31) (others being Reis-Bucklers, Thiel-Behnke, lattice types I and IIIA, epithelial basement membrane disease, and Avellino). These are therefore allelic disorders of the same mutant gene.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be temporarily helpful in restoring vision but recurrence is common.  Opacities may also occur following the application of various types of refractive surgery (even in initially clear corneas).

References
Article Title: 

Pages

Subscribe to RSS - autosomal dominant